Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sticky patch may spare sick kids painful needle sticks

NCT ID NCT07478380

Knowledge-focused Sponsor: Istanbul Medeniyet University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a noninvasive skin sensor can accurately measure oxygen and carbon dioxide levels in critically ill children in the intensive care unit. Currently, doctors rely on arterial blood draws, which are painful and invasive. The researchers will compare readings from the sensor with standard blood tests in 50 children to see if the sensor is reliable enough to reduce the need for needles.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that a simple skin sensor is accurate enough to replace some blood tests in sick children, making monitoring less painful and more continuous.
What could go wrong
This is a small observational study (50 children) that only checks how well the sensor matches blood tests. It won't prove the sensor works in all situations, and results may not apply to unstable patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study will include pediatric patients aged 1 month to 18 years admitted to the Pediatric Intensive Care Unit (PICU) who undergo arterial blood gas analysis and concurrent transcutaneous pCO₂ and pO₂ monitoring as part of routine clinical care. Patients with an indwelling arterial catheter and adequate peripheral perfusion allowing reliable transcutaneous measurements will be eligible. The study population represents critically ill children requiring close respiratory and hemodynamic monitoring in the PICU setting.

Ages

1 month to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Eligibility Criteria Inclusion Criteria: * Age between 1 month and 18 years * Admission to the Pediatric Intensive Care Unit (PICU) * Presence of an arterial catheter allowing arterial blood gas (ABG) sampling * Simultaneous or paired transcutaneous pCO₂ and pO₂ monitoring available * Hemodynamically stable at the time of measurement Exclusion Criteria: * Severe skin disease, burns, or local skin infection at the transcutaneous sensor site * Severe peripheral perfusion impairment (e.g., refractory shock or high-dose vasopressor support) * Congenital or acquired conditions interfering with accurate transcutaneous measurements * Technical failure or inability to obtain reliable transcutaneous readings * Missing or incomplete paired ABG-transcutaneous measurement data

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pediatric critical illness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pediatric critical illness

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Göztepe Prof. Dr. Süleyman Yalçın City Hospital

    RECRUITING

    Istanbul, Kadıkoy, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.